Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 Activation

• Published in: The Journal of biological chemistry Vol. 281; no. 36; pp. 26408 - 26418
• Main Authors: Seidler, Daniela G., Goldoni, Silvia, Agnew, Christopher, Cardi, Christopher, Thakur, Mathew L., Owens, Rick T., McQuillan, David J., Iozzo, Renato V.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 08.09.2006; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Apoptosis - physiology; Carcinoma, Squamous Cell - metabolism; Caspase 3 - metabolism; Cell Line, Tumor; Decorin; DNA Fragmentation; Enzyme Activation; ErbB Receptors - genetics; ErbB Receptors - metabolism; Extracellular Matrix Proteins - administration & dosage; Extracellular Matrix Proteins - genetics; Extracellular Matrix Proteins - metabolism; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms - metabolism; Proteoglycans - administration & dosage; Proteoglycans - genetics; Proteoglycans - metabolism; Transplantation, Heterologous
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M602853200

Decorin is not only a regulator of matrix assembly but also a key signaling molecule that modulates the activity of tyrosine kinase receptors such as the epidermal growth factor receptor (EGFR). Decorin evokes protracted internalization of the EGFR via a caveolar-mediated endocytosis, which leads to EGFR degradation and attenuation of its signaling pathway. In this study, we tested if systemic delivery of decorin protein core would affect the biology of an orthotopic squamous carcinoma xenograft. After tumor engraftment, the animals were given intraperitoneal injections of either vehicle or decorin protein core (2.5-10 mg kg-1) every 2 days for 18-38 days. This regimen caused a significant and dose-dependent inhibition of the tumor xenograft growth, with a concurrent decrease in mitotic index and a significant increase in apoptosis. Positron emission tomography showed that the metabolic activity of the tumor xenografts was significantly reduced by decorin treatment. Decorin protein core specifically targeted the tumor cells enriched in EGFR and caused a significant down-regulation of EGFR and attenuation of its activity. In vitro studies showed that the uptake of decorin by the A431 cells was rapid and caused a protracted down-regulation of the EGFR to levels similar to those observed in the tumor xenografts. Furthermore, decorin induced apoptosis via activation of caspase-3. This could represent an additional mechanism whereby decorin might influence cell growth and survival.